<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>15017</id><no>CY6033-NCT06081894</no><status>Open (affiliates only)</status><title>AFICAMTEN (CK-3773274)&#xD;
PROTOCOL CY 6033&#xD;
A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN COMPARED TO PLACEBO IN ADULTS WITH SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY</title><nct_id>NCT06081894</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><disease_site>Diseases Of The Circulatory System</disease_site><PI>Bering, Patrick; Jani, Sandeep</PI><institution>Medstar Washington Hospital Center</institution></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>